BRIEF-Trifecta Health Cooperated With Eli Lilly To Provide Patients With Access To Zepbound Single-Dose Vials

Reuters
22 hours ago
BRIEF-Trifecta Health Cooperated With Eli Lilly To Provide Patients With Access To Zepbound Single-Dose Vials

Nov 11 (Reuters) - Eli Lilly and Co LLY.N:

  • TRIFECTA HEALTH: CO, TRIFECTA MED SPA COOPERATED WITH ELI LILLY TO PROVIDE PATIENTS WITH ACCESS TO ZEPBOUND SINGLE-DOSE VIALS

  • TRIFECTA HEALTH: COOPERATION WITH LILLYDIRECT PHARMACY CHANNEL WILL ALLOW PATIENTS TO RECEIVE ZEPBOUND DELIVERED DIRECTLY TO THEM AT SELF-PAY PRICE

  • TRIFECTA HEALTH: CO, TRIFECTA MED SPA COOPERATED WITH NOVOCARE PHARMACY TO OFFER ACCESS TO WEGOVY AT LOWEST CASH PRICE AVAILABLE

Source text: ID:nPn6Kfgrna

Further company coverage: LLY.N

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10